<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="89047">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01921452</url>
  </required_header>
  <id_info>
    <org_study_id>EMR 200125_507</org_study_id>
    <nct_id>NCT01921452</nct_id>
  </id_info>
  <brief_title>Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit</brief_title>
  <official_title>A Single-center Interventional Study to Verify Clinical Utility of the Quantitative and the Qualitative POC TSH Test Kits Compared With the Third Generation TSH Test Kit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck KGaA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck KGaA</source>
  <oversight_info>
    <authority>China: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a Phase 4, single-center, open-label, interventional study, wherein 274 subjects
      will be enrolled, who will be tested for Thyroid Stimulating Hormone (TSH) by using the
      quantitative and the qualitative Point-of-Care (POC) TSH test kits and the third generation
      TSH test kit at the same time.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Qualitative (Positive and Negative) Thyroid Stimulating Hormone (TSH) levels</measure>
    <time_frame>Up to Day 5 after enrolment</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Absolute concentration of Thyroid Stimulating Hormone (TSH)</measure>
    <time_frame>Up to Day 5 after enrolment</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">274</enrollment>
  <condition>Hypothyroidism</condition>
  <arm_group>
    <arm_group_label>POC TSH kits</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Third generation TSH kit</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Quantitative POC TSH kit</intervention_name>
    <description>A drop of blood will be taken from subject's fingertip to test TSH quantitatively by using the quantitative POC TSH test kit according to the product specification on Visit 1 (that is, Day 1 to Day 5 after enrolment).</description>
    <arm_group_label>POC TSH kits</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Qualitative POC TSH kit</intervention_name>
    <description>A drop of blood will be taken from subject's fingertip to test TSH qualitatively by using the qualitative POC TSH test kit according to the product specification on Visit 1 (that is, Day 1 to Day 5 after enrolment).</description>
    <arm_group_label>POC TSH kits</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Third generation TSH kit</intervention_name>
    <description>Subject's venous blood will be taken to test TSH levels,  by using the third generation TSH test kit in the central laboratory of the hospital on Visit 1 (that is, Day 1 to Day 5 after enrolment).</description>
    <arm_group_label>Third generation TSH kit</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Suspected hypothyroidism subject

          -  Signed informed consent document

        Exclusion Criteria:

          -  Legal incapacity or limited legal capacity

          -  Unwilling or unable to complete the study or not ready to sign the informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Merck KGaA Communication Center</last_name>
    <phone>+49 6151 72 5200</phone>
    <email>service@merckgroup.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Research site</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 13, 2014</lastchanged_date>
  <firstreceived_date>August 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypothyroidism</keyword>
  <keyword>Third generation TSH kit</keyword>
  <keyword>Quantitative POC TSH kit</keyword>
  <keyword>Qualitative POC TSH kit</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypothyroidism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
